SEC Form 3 · accession 0001178913-18-003031
Foamix Pharmaceuticals Ltd. · FOMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony D Bruno
Director
Period of report
Nov 14, 2018
Accepted (ET)
Nov 26, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606645
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | holding | — | — | — | 41,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $7.98 | holding | — | — | — | — | Feb 26, 2019 | Ordinary Shares | 15,625 | — | D |
Explanation of responses
- F1The Options became exercisable in four equal annual installments beginning on June 9, 2015 and ending on June 9, 2018.